Gabriel Soo
参与了投票
嘿 mooer们,
欢迎来到 六月的Moo精选, 在这里,我们将回顾热闹的股票、市场和摩尔的交易分析,以及moomoo上的冷静时光。
美联储将基准利率提高了 0.75%, 这是自1994年以来的最大涨幅。随着标准普尔500指数确认熊市,埃隆·马斯克对推特的收购仍在继续。让我们来看看六月的旅程。
你想到什么热门股票吗?我们已经为你收集了十个。
Buzzing 股票清单
查看更多>>
@iamiam
...
欢迎来到 六月的Moo精选, 在这里,我们将回顾热闹的股票、市场和摩尔的交易分析,以及moomoo上的冷静时光。
美联储将基准利率提高了 0.75%, 这是自1994年以来的最大涨幅。随着标准普尔500指数确认熊市,埃隆·马斯克对推特的收购仍在继续。让我们来看看六月的旅程。
你想到什么热门股票吗?我们已经为你收集了十个。
Buzzing 股票清单
查看更多>>
@iamiam
...
已翻译
+5
216
57
Gabriel Soo
赞了
我的 youtube 频道:
https://www.youtube.com/channel/UCAPWOEQKCpCWmzKkdo7v-iw
小米今天终于表现出了韧性,先是突破20,然后是19港元,然后是18.22港元,今天小幅上涨了18.12港元,跌至18.22港元。自恒生科技股跌幅接近2.5%以来,这被认为是一种祝福。快手科技、阿里巴巴、哔哩哔哩、网易、美团等公司均下跌了近3%...好吧,难道是小米已经跌到了价值区间,还以为它走得更远没有意义吗?
我不能肯定地这么说,但是芯片短缺、不良的红外处理技能、中国和其他市场的手机竞争以及对电动汽车部门的资本担忧可能会给小米带来压力...但是那又怎样?甚至有人担心雷军必须从关键业务部门辞职,这可能预示着一些问题。
话又说回来,当雷军成为小米Venture Cap或私募股权部门的控股人时,对雷军的恐慌情绪减弱了,这也许可以解释当今的韧性。当然,另一部分可能是小米自己的股票回购。尽管股票回购从27港元一直降至18港元,但这种股票回购仍然显得苍白无力,当叙事和可以说的下行压力给小米带来压力时,这种股票回购是行不通的。
但是价值最终会出现... 17港元的首次公开募股价格会提供强有力的支撑吗?只有时间会证明一切,但我是小米的真正长期投资者...
如果你想知道我为什么相信小米,可以看看我在小米上拍的这段YouTube视频:
https://www.youtube.com/watch?v=glRHKF1fQkU
与往常一样,这不应被解释为任何投资或交易建议。
$小米集团-W (01810.HK)$ $小米集团(ADR) (XIACY.US)$ $LENOVO B2401 (05562.HK)$ $海尔智家 (600690.SH)$ $海尔智家 (06690.HK)$
https://www.youtube.com/channel/UCAPWOEQKCpCWmzKkdo7v-iw
小米今天终于表现出了韧性,先是突破20,然后是19港元,然后是18.22港元,今天小幅上涨了18.12港元,跌至18.22港元。自恒生科技股跌幅接近2.5%以来,这被认为是一种祝福。快手科技、阿里巴巴、哔哩哔哩、网易、美团等公司均下跌了近3%...好吧,难道是小米已经跌到了价值区间,还以为它走得更远没有意义吗?
我不能肯定地这么说,但是芯片短缺、不良的红外处理技能、中国和其他市场的手机竞争以及对电动汽车部门的资本担忧可能会给小米带来压力...但是那又怎样?甚至有人担心雷军必须从关键业务部门辞职,这可能预示着一些问题。
话又说回来,当雷军成为小米Venture Cap或私募股权部门的控股人时,对雷军的恐慌情绪减弱了,这也许可以解释当今的韧性。当然,另一部分可能是小米自己的股票回购。尽管股票回购从27港元一直降至18港元,但这种股票回购仍然显得苍白无力,当叙事和可以说的下行压力给小米带来压力时,这种股票回购是行不通的。
但是价值最终会出现... 17港元的首次公开募股价格会提供强有力的支撑吗?只有时间会证明一切,但我是小米的真正长期投资者...
如果你想知道我为什么相信小米,可以看看我在小米上拍的这段YouTube视频:
https://www.youtube.com/watch?v=glRHKF1fQkU
与往常一样,这不应被解释为任何投资或交易建议。
$小米集团-W (01810.HK)$ $小米集团(ADR) (XIACY.US)$ $LENOVO B2401 (05562.HK)$ $海尔智家 (600690.SH)$ $海尔智家 (06690.HK)$
已翻译
59
Gabriel Soo
赞了
$辉瑞 (PFE.US)$ People who have previously had Covid or been vaccinated have far less protection against omicron than they do for other variants, according to the first data of its kind.
Scientists from South Africa grew live samples ofthe omicron variantand performed lab experiments to see if, and how, omicron was affected by antibodies in blood samples from 12 people who had been vaccinated. Six of the people also had previously had Covid.
The world has been waiting for these neutralising studies to gauge how pre-existing immunity from both vaccination and prior infection will hold up againstomicron.
The study shows how many antibodies are needed in order to stop the virus from replicating and is an early indicator of how effective the worrying new variant is at avoiding our immune system.
In reality, the picture is far more complex as human immune systems have other lines of defence that work in tandem with antibodies, such as T-cells.
The new study is the first to showhow omicron compares to previous variants, such as beta and delta, on a level playing field and the preliminary data shows antibodies in blood samples are 41 times less effective for omicron than for the 2020 strain.
“This doesn't mean vaccines will be 40x less effective,” said Dr Muge Cevik, an infectious disease expert at the University of St Andrews who was not involved in the research.
$Moderna (MRNA.US)$ $BioNTech (BNTX.US)$ $诺瓦瓦克斯医药 (NVAX.US)$
Part of the content is taken from Yahoo.
Scientists from South Africa grew live samples ofthe omicron variantand performed lab experiments to see if, and how, omicron was affected by antibodies in blood samples from 12 people who had been vaccinated. Six of the people also had previously had Covid.
The world has been waiting for these neutralising studies to gauge how pre-existing immunity from both vaccination and prior infection will hold up againstomicron.
The study shows how many antibodies are needed in order to stop the virus from replicating and is an early indicator of how effective the worrying new variant is at avoiding our immune system.
In reality, the picture is far more complex as human immune systems have other lines of defence that work in tandem with antibodies, such as T-cells.
The new study is the first to showhow omicron compares to previous variants, such as beta and delta, on a level playing field and the preliminary data shows antibodies in blood samples are 41 times less effective for omicron than for the 2020 strain.
“This doesn't mean vaccines will be 40x less effective,” said Dr Muge Cevik, an infectious disease expert at the University of St Andrews who was not involved in the research.
$Moderna (MRNA.US)$ $BioNTech (BNTX.US)$ $诺瓦瓦克斯医药 (NVAX.US)$
Part of the content is taken from Yahoo.
9